top of page
MONA Brandmanual BtoC.png
MONA LOGO_edited_edited_edited_edited.png

The Next Generation

Enhancing Your Juvenation

MONA envisions the next generation in aesthetics: less invasive, more natural. MONA supports the body in amplifying what’s already there—for subtle, authentic beauty from within.

Through our advanced PTMC microsphere technology. MONA enhances your own regenerative power and restores your juvenation

Before & After

Bio-design

Bio-Designed reflects our commitment to harmonizing advanced medical science with the natural regenerative capacity of the human body. Our dermal filler, MONA, exemplifies this principle through the use of polytrimethylene carbonate (PTMC)—a next-generation, bioresorbable polymer specifically chosen for its biocompatibility and gentle integrationwith human tissue.

Bio-compatible

MONA offers a gentler approach to tissue regeneration. Their smooth, uniform particles reduce injection trauma and integrate evenly with tissue. Unlike fillers that fragment or release acidic byproducts, MONA degrades gradually through surface erosion—minimizing inflammation and tissue irritation. Fully bioresorbable and non-crystalline, they support healing with minimal disruption.

Bio-degradation

MONA degrades layer by layer. This mechanism is mediated by the enzymes in your body and offers a steady and even resorption over time, reducing the risk of long-term complications.

ChatGPT Image 10 dec 2025, 14_21_39.png

WHY MONA

Through innovative PTMC technology, we provide an advanced and sustainable alternative to traditional dermal fillers. MONA collaborates with specialists to deliver safe, long-lasting, and natural results- helping clients not only maintain a youthful look but also feel stronger and more confident in themselves.

Controlled and predictable degradation profile

Optimal tissue integration and collagen regeneration for lasting results

Low biological inflammatory responses for patient comfort and safety

Disclaimer

MONA is under clinical investigation and has not yet received commercial approval. We are conducting clinical studies to establish its safety and efficancy profile in compliance with regulatory requirements. All claims made are beging clinically investigated 

bottom of page